Your session is about to expire
← Back to Search
Combined real tDCS + IST for Aphasia
N/A
Waitlist Available
Led By Thomas Marquardt, Ph.D.
Research Sponsored by Austin Speech Labs
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Have suffered a left CVA
Demonstrate 50% or greater on the Auditory Verbal Comprehension section of the WAB
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after eight weeks of treatment
Awards & highlights
Study Summary
The purpose of this study is to determine if transcranial direct current stimulation (tDCS) in conjunction with intensive speech therapy will improve sentence production and word retrieval in individuals with chronic post stroke aphasia.
Eligible Conditions
- Aphasia
- Language Disorder
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ after eight weeks of treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after eight weeks of treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Improvement in naming Action verbs as measured by Northwestern Assessment Verbs Sentences
Improvement in naming nouns as measured by Object Naming Test
Improvement in sentence production as measured by NAVS
Secondary outcome measures
Improvement in picture description as measured by Western Aphasia Battery
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Combined real tDCS + ISTExperimental Treatment2 Interventions
Participants will receive tDCS via a Starstim device at 1mA for 20min of the total three hours of intensive speech therapy time at the beginning of each session. The stimulation will be ramped up for 45 seconds and ramped down for 15 seconds. For the experimental group, the stimulation will be ramped up for 45 seconds and stay there for 20 min. The participants will receive three weeks of tDCS and continue receiving only intensive speech therapy for five weeks for three hours a day.
Group II: Combined sham tDCS + ISTPlacebo Group2 Interventions
Participants will receive tDCS via a Starstim device at 1mA for 20min of the total three hours of intensive speech therapy time at the beginning of each session. For the sham group, the stimulation will be ramped up for 45 seconds and ramped down for 15 seconds. The stimulation will be ramped up for 45 seconds and then ramp down after the initial 45 seconds. The participants will receive three weeks of tDCS and continue receiving only intensive speech therapy for five weeks for three hours a day.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Real tDCS
2016
N/A
~210
Find a Location
Who is running the clinical trial?
Austin Speech LabsLead Sponsor
1 Previous Clinical Trials
20 Total Patients Enrolled
1 Trials studying Aphasia
20 Patients Enrolled for Aphasia
Burke Medical Research InstituteOTHER
23 Previous Clinical Trials
1,459 Total Patients Enrolled
University of TexasOTHER
187 Previous Clinical Trials
142,495 Total Patients Enrolled
1 Trials studying Aphasia
10 Patients Enrolled for Aphasia
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger